Delivery Order SPE2DB20D3103-SPE2DB23FN4D6
- Not listed
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order contract worth $1,726.81 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 50 mg Doxorubicin vials. This Delivery Order contract is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,949.46 firm fixed price delivery order is for the supply of 4,565,683,731 units of the medication Doxorubicin 200 mg/100 ml vial. The award has an ultimate completion date of September 5, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $5,400.00 fixed-price delivery order is for the supply of 4,564,081,943 units of Doxorubicin Liposome 20mg/10ml 10ml, a specialty pharmaceutical product, with a performance period through March 27, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up...
- This federal contract award, valued at $12,137.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4558476980 DOXY 100 MG VIALS, with an ultimate completion date of September 16, 2022. This order is placed under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award, with a value of $1,730.43, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle for the DLA to procure a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
- This federal contract award is a delivery order (SPE2DB20D3103|SPE2DB24FM4V2) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4563493004 - Doxorubicin Liposome 50mg/25ml 25ml. The $1,500.00 firm fixed price award was made by the Defense Logistics Agency (DLA) on January 30, 2024, with a completion date of January 31, 2024. The contract does not have a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award is for a Delivery Order placed by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD), with AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,878.48, is for the provision of various pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, and other critical care materials such as syringes and vials. This Delivery Order is...
- This federal contract award is to AmerisourceBergen Drug Corp for the delivery of Doxorubicin Liposome 50mg/25ml 25ml to the Defense Logistics Agency (DLA). The contract, valued at $2,199.00, is a delivery order with a firm fixed price. The ultimate completion date is August 13, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds multiple Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued up...
- This federal contract award, valued at $1,125.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
- This federal contract award, valued at $1,708.20, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order under DLA's Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which runs through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities,...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FN4D6Delivery Order
This federal contract award, valued at $1,071.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for 4,560,957,401 units of Doxorubicin 50 mg/25 ml Vial with a fixed-price of $1,071.00 and a completion date of May 17, 2023. This award is a child contract under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This delivery order is part of AmerisourceBergen's extensive portfolio of federal contract awards with various agencies, including the Department of Justice Federal Bureau of Investigation, demonstrating the company's critical role in supplying essential medical commodities to the U.S. government.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 5/16/23 |